PCA
TMO icon

Pallas Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Pallas Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$588K Sell
1,197
-59
-5% -$32K 0.02% 461
2025
Q4 		$728K Buy
1,256
+18
+1% +$10.2K 0.02% 437
2025
Q3 		$601K Sell
1,238
-852
-41% -$397K 0.02% 469
2025
Q2 		$847K Sell
2,090
-10,535
-83% -$4.4M 0.03% 366
2025
Q1 		$6.28M Buy
12,625
+640
+5% +$347K 0.26% 80
2024
Q4 		$6.23M Buy
11,985
+233
+2% +$128K 0.27% 79
2024
Q3 		$6.55M Buy
11,752
+76
+0.7% +$45K 0.28% 77
2024
Q2 		$6.31M Buy
11,676
+418
+4% +$239K 0.28% 75
2024
Q1 		$6.54M Buy
11,258
+1,161
+11% +$651K 0.27% 73
2023
Q4 		$5.36M Sell
10,097
-1,506
-13% -$729K 0.29% 76
2023
Q3 		$5.04M Buy
11,603
+2,555
+28% +$1.36M 0.31% 70
2023
Q2 		$4.75M Buy
9,048
+146
+2% +$78.8K 0.21% 69
2023
Q1 		$5.11M Buy
8,902
+521
+6% +$294K 0.48% 63
2022
Q4 		$4.98M Sell
8,381
-42
-0.5% -$22.3K 0.5% 57
2022
Q3 		$4.1M Buy
8,423
+390
+5% +$218K 0.46% 67
2022
Q2 		$4.51M Sell
8,033
-393
-5% -$216K 0.62% 48
2022
Q1 		$4.79M Buy
8,426
+316
+4% +$182K 0.61% 49
2021
Q4 		$4.71M Buy
8,110
+439
+6% +$274K 0.57% 44
2021
Q3 		$4.93M Buy
7,671
+1,812
+31% +$995K 0.54% 46
2021
Q2 		$3.16M Buy
5,859
+921
+19% +$435K 0.44% 57
2021
Q1 		$2.29M Buy
+4,938
New +$2.36M 0.51% 47

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pallas Capital Advisors's TMO Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 4.7% in Q1 2026, selling an estimated $32K and leaving 1,197 shares worth $588K. The position accounts for 0.02% of the portfolio, ranked #461.

Pallas Capital Advisors first reported a position in TMO in Q1 2021 and has held it in 21 quarters since. The position peaked at $6.55M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Pallas Capital Advisors held 1,197 shares of Thermo Fisher Scientific worth $588K as of Q1 2026.
  • Pallas Capital Advisors sold 59 Thermo Fisher Scientific shares in Q1 2026, an estimated $32K.
  • Thermo Fisher Scientific made up 0.02% of Pallas Capital Advisors's portfolio in Q1 2026, its #461 holding.
  • Pallas Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 21 quarters since.
  • Pallas Capital Advisors's Thermo Fisher Scientific position peaked at $6.55M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.